- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03899662
Neurophysiological Evaluation of Schizophrenia Patients After Cognitive and Physical Intervention
February 13, 2020 updated by: Panos Bamidis, Aristotle University Of Thessaloniki
A Neurophysiological Investigation of the Effectiveness of Web-based Exergaming Platform of Cognitive and Physical Training in Schizophrenic Patients
Neurophysilogical, neuropsychological evaluation and cognitive and physical training
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
24 sessions (8 weeks, 3 times per week) of cognitive and physical training via computer.
Each session consisted of 45 minutes of cognitive traing (BrainHQ platform https://www.brainhq.com/)
and 45 minutes of physical training (FitForAll platform https://www.fitforall.gr/play/app/).
Cognitive training included memory, attention, velocity, intelligence etc. Physical training included aerobic, strength flexibility and other excercises.
All evaluations were performed 1-14 before the initiation of the interventions and 1-14 after their completion.
Neurophysiological evaluation consisted of EEG with the use of 128 electrode-machine and the protocol included 5 minuted of eyes closed and 5 minutes of eyes open.
Neuropsychological evaluation included Trail Making Test (A & B), Verbal Fluency, Stroop test, Wechsler Memory - Cubes (visuospatial), MoCA, FAB (Screening for frontal damage) and Eyes Test (Theory of Mind).
Also, the physical condition evaluation included 6-Minute Walking Distance (6MWD), ΒΜΙ, HandGrip Strength Test, Short Physical Performance Battery Protocol.
Study Type
Interventional
Enrollment (Actual)
4
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Thessaloniki, Greece
- Laboratory of Medical Physics, AUTH
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- a diagnosis of schizophrenia disorder according to ICD10 criteria
- clinically stable patients (no recent change in psychotropic medication except benzodiazepines)
- sufficient acculturation and fluency in Greek language
- assent of the attending physician for participation in the study
Exclusion Criteria:
- co-morbidity with neurological disorders (e.g.epilepsy) or head injury
- a pathological or other somatic disorder that contraindicate physical exercise
- alcoholism and substance abuse within the previous 3 months (except caffeine and tobacco)
- abstainance from intervention for more than 12 days
- cognitive decline
- treated with Benzodiazepine
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cognitive and Physical Training
24 sessions (8 weeks, 3 times per week) of computer based 45 minute cognitive and 45 minute physical training.
|
Cognitive training included memory, attention, velocity, intelligence
Physical training included aerobic, strength, flexibility and balance.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Alterations in functional connectivity properties and on the organization of resting state networks
Time Frame: 3 months
|
Alterations in functional connectivity properties and on the organization of resting state networks quantified through graph theory tools.
These measures would be measured through high-density electroencephalographic (EEG) evaluation and reconstruction of cortical activity.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical fitness
Time Frame: 2 months
|
Estimated through 6-Minute Walking Distance (6MWD)
|
2 months
|
|
Physical fitness
Time Frame: 2 months
|
Estimated through ΒΜΙ
|
2 months
|
|
Physical fitness
Time Frame: 2 months
|
Estimated through HandGrip Strength Test
|
2 months
|
|
Physical fitness
Time Frame: 2 months
|
Estimated through Short Physical Performance Battery Protocol
|
2 months
|
|
Memory
Time Frame: 2 months
|
Estimated through Wechsler Memory - Cubes (visuospatial) test
|
2 months
|
|
Executive function
Time Frame: 2 months
|
Estimated through FAB (Frontalassesment test)
|
2 months
|
|
Depressive syndromes
Time Frame: 2 months
|
Estimated through Had's test
|
2 months
|
|
Theory of mind
Time Frame: 2 months
|
Estimated through Eye's test
|
2 months
|
|
Verbal fluency
Time Frame: 2 months
|
Estimated through Verbal Fluency test
|
2 months
|
|
Visual attention and task switching
Time Frame: 2 months
|
Estimated through Trail Making A & B test
|
2 months
|
|
Reaction time
Time Frame: 2 months
|
Estimated through Stroop test
|
2 months
|
|
Generic cogntive impairment
Time Frame: 2 months
|
Estimated through Montreal Cognitive Assessment (MoCA) test
|
2 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Panagiotis Bamidis, PhD, Associate Professor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Whitfield-Gabrieli S, Thermenos HW, Milanovic S, Tsuang MT, Faraone SV, McCarley RW, Shenton ME, Green AI, Nieto-Castanon A, LaViolette P, Wojcik J, Gabrieli JD, Seidman LJ. Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1279-84. doi: 10.1073/pnas.0809141106. Epub 2009 Jan 21. Erratum In: Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4572.
- Frantzidis CA, Ladas AK, Vivas AB, Tsolaki M, Bamidis PD. Cognitive and physical training for the elderly: evaluating outcome efficacy by means of neurophysiological synchronization. Int J Psychophysiol. 2014 Jul;93(1):1-11. doi: 10.1016/j.ijpsycho.2014.01.007. Epub 2014 Jan 25.
- Hemsley DR. The development of a cognitive model of schizophrenia: placing it in context. Neurosci Biobehav Rev. 2005;29(6):977-88. doi: 10.1016/j.neubiorev.2004.12.008.
- Tagliazucchi E, von Wegner F, Morzelewski A, Borisov S, Jahnke K, Laufs H. Corrigendum to "Automatic sleep staging using fMRI functional connectivity data" [Neuroimage 63/1 (2012) 63-72]. Neuroimage. 2013 Nov 1;81:506. doi: 10.1016/j.neuroimage.2013.05.048. Epub 2013 May 23. No abstract available.
- Frantzidis CA, Vivas AB, Tsolaki A, Klados MA, Tsolaki M, Bamidis PD. Functional disorganization of small-world brain networks in mild Alzheimer's Disease and amnestic Mild Cognitive Impairment: an EEG study using Relative Wavelet Entropy (RWE). Front Aging Neurosci. 2014 Aug 26;6:224. doi: 10.3389/fnagi.2014.00224. eCollection 2014.
- Konstantinidis EI, Billis AS, Mouzakidis CA, Zilidou VI, Antoniou PE, Bamidis PD. Design, Implementation, and Wide Pilot Deployment of FitForAll: An Easy to use Exergaming Platform Improving Physical Fitness and Life Quality of Senior Citizens. IEEE J Biomed Health Inform. 2016 Jan;20(1):189-200. doi: 10.1109/JBHI.2014.2378814.
- Arbabshirani MR, Kiehl KA, Pearlson GD, Calhoun VD. Classification of schizophrenia patients based on resting-state functional network connectivity. Front Neurosci. 2013 Jul 30;7:133. doi: 10.3389/fnins.2013.00133. eCollection 2013.
- Bamidis PD, Fissler P, Papageorgiou SG, Zilidou V, Konstantinidis EI, Billis AS, Romanopoulou E, Karagianni M, Beratis I, Tsapanou A, Tsilikopoulou G, Grigoriadou E, Ladas A, Kyrillidou A, Tsolaki A, Frantzidis C, Sidiropoulos E, Siountas A, Matsi S, Papatriantafyllou J, Margioti E, Nika A, Schlee W, Elbert T, Tsolaki M, Vivas AB, Kolassa IT. Gains in cognition through combined cognitive and physical training: the role of training dosage and severity of neurocognitive disorder. Front Aging Neurosci. 2015 Aug 7;7:152. doi: 10.3389/fnagi.2015.00152. eCollection 2015.
- Rosazza C, Minati L. Resting-state brain networks: literature review and clinical applications. Neurol Sci. 2011 Oct;32(5):773-85. doi: 10.1007/s10072-011-0636-y. Epub 2011 Jun 11.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 30, 2018
Primary Completion (Actual)
July 31, 2019
Study Completion (Actual)
July 31, 2019
Study Registration Dates
First Submitted
March 29, 2019
First Submitted That Met QC Criteria
April 1, 2019
First Posted (Actual)
April 2, 2019
Study Record Updates
Last Update Posted (Actual)
February 17, 2020
Last Update Submitted That Met QC Criteria
February 13, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SCH15973
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
Fundació Institut de Recerca de l'Hospital de la...Recruiting
-
First Affiliated Hospital of Fujian Medical UniversityNot yet recruiting
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Newron Pharmaceuticals SPARecruitingTreatment-resistant SchizophreniaUnited States, India
-
Bradley LegaRecruiting
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Second Xiangya Hospital of Central South UniversityNot yet recruiting
-
Kaohsiung Medical University Chung-Ho Memorial...Not yet recruitingSchizophrenia Disorder
-
All India Institute of Medical Sciences, BhubaneswarCompletedTreatment Resistant SchizophreniaIndia
-
Shanghai Zhongze Therapeutics Co., Ltd.Yale UniversityNot yet recruiting
Clinical Trials on Cognitive Training
-
Science and Research Centre KoperAlbert Einstein College of Medicine; University of Primorska; Vrije Universiteit...CompletedEffects of Cognitive Intervention on Cognition, Mobility and Brain Electrocortical Activity (GIBKOP)Cognitive Impairment | Aging | Cognitive Decline | Motor Coordination or FunctionSlovenia
-
Hospital de Clinicas de Porto AlegreYale UniversityUnknownAttention-deficit/Hyperactivity Disorder.Brazil
-
Universidade Federal do Rio de JaneiroUnknown
-
Xuanwu Hospital, BeijingRecruitingMild Cognitive ImpairmentChina
-
Chang Gung Memorial HospitalRecruitingVirtual Reality | Community-dwelling ElderlyTaiwan
-
Fanfan ZhengEnrolling by invitationDiabetes Mellitus, Type 2 | Aging | CognitionChina
-
Fundació Sant Joan de DéuCompletedIndication for Modification of Patient Cognitive StatusSpain
-
Chiang Mai UniversityCompletedMild Cognitive ImpairmentThailand
-
Chang Gung Memorial HospitalRecruitingMCI | SCD | Virtual RealityTaiwan
-
University of California, San FranciscoCompletedSchizophrenia | PsychosisUnited States